Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

被引：0

作者：

Lukas Donix

Holger H. H. Erb

Claudia Peitzsch

Anna Dubrovska

Manuel Pfeifer

Christian Thomas

Susanne Fuessel

Kati Erdmann

机构：

[1] Technische Universität Dresden,Department of Urology, Faculty of Medicine

[2] National Center for Tumor Diseases (NCT),National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine

[3] Dresden,Helmholtz

[4] Germany: German Cancer Research Center (DKFZ),Zentrum Dresden

[5] Heidelberg,Rossendorf

[6] Germany; Faculty of Medicine and University Hospital Carl Gustav Carus,Institute of Legal Medicine, Faculty of Medicine

[7] Technische Universität Dresden,undefined

[8] Dresden,undefined

[9] Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR),undefined

[10] Technische Universität Dresden,undefined

[11] Institute of Radiooncology - OncoRay,undefined

[12] German Cancer Consortium (DKTK),undefined

[13] Partner Site Dresden,undefined

[14] Dresden and German Cancer Research Center (DKFZ),undefined

[15] Technische Universität Dresden,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Cisplatin; Docetaxel; mCRPC; NEPC; Prostate cancer; Radiotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1313 / 1324

页数：11

共 50 条

[1] Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
Donix, Lukas
Erb, Holger H. H.
Peitzsch, Claudia
Dubrovska, Anna
Pfeifer, Manuel
Thomas, Christian
Fuessel, Susanne
Erdmann, Kati
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (06) : 1313 - 1324
[2] Cross-resistance to cisplatin in cells with acquired resistance to copper
Roohangiz Safaei
Kuniyuki Katano
Goli Samimi
Wiltrud Naerdemann
Jennifer L. Stevenson
Myriam Rochdi
Stephen B. Howell
Cancer Chemotherapy and Pharmacology, 2004, 53 : 239 - 246
[3] Cross-resistance to cisplatin in cells with acquired resistance to copper
Safaei, R
Katano, K
Samimi, G
Naerdemann, W
Stevenson, JL
Rochdi, M
Howell, SB
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (03) : 239 - 246
[4] Cross-resistance and drug sequence in prostate cancer
Buck, Stefan A. J.
Koolen, Stijn L. W.
Mathijssen, Ron H. J.
de Wit, Ronald
van Soest, Robert J.
DRUG RESISTANCE UPDATES, 2021, 56
[5] Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance
Jenkins, Samir V.
Shah, Shruti
Jamshidi-Parsian, Azemat
Mortazavi, Amir
Kristian, Hailey
Boysen, Gunnar
Vang, Kieng B.
Griffin, Robert J.
Rajaram, Narasimhan
Dings, Ruud P. M.
RADIATION RESEARCH, 2024, 201 (02) : 174 - 187
[6] Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines
Kitazono-Saitoh, Miyako
Takiguchi, Yuichi
Kitazono, Satoru
Ashinuma, Hironori
Kitamura, Atsushi
Tada, Yuji
Kurosu, Katsushi
Sakaida, Emiko
Sekine, Ikuo
Tanabe, Nobuhiro
Tagawa, Masatoshi
Tatsumii, Koichiro
ONCOLOGY REPORTS, 2012, 28 (01) : 33 - 40
[7] Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance
Cahuzac, Maxime
Peant, Benjamin
Mes-Masson, Anne-Marie
Saad, Fred
CANCERS, 2022, 14 (16)
[8] RBPJ contributes to acquired docetaxel resistance in prostate cancer cells
Li Xue
Zhenlong Wang
Hecheng Li
Zhaolun Li
Qi Chen
Peng Zhang
Haiwen Chen
Ziming Wang
Tie Chong
Molecular & Cellular Toxicology, 2017, 13 : 279 - 285
[9] Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel
Putten, Eric van der
Wosikowski, Katja
Beijnen, Jos H.
Imre, Gabor
Freund, Colin R.
CANCER DRUG RESISTANCE, 2024, 7
[10] RBPJ contributes to acquired docetaxel resistance in prostate cancer cells
Xue, Li
Wang, Zhenlong
Li, Hecheng
Li, Zhaolun
Chen, Qi
Zhang, Peng
Chen, Haiwen
Wang, Ziming
Chong, Tie
MOLECULAR & CELLULAR TOXICOLOGY, 2017, 13 (03) : 279 - 285

← 1 2 3 4 5 →